Background: Spinal cord stimulation (SCS) is a form of neuromodulation, used to treat chronic
neuropathic pain refractory to conventional medical management. Spinal cord stimulators are
treatment options when intractable chronic pain has not responded to more conventional treatment
modalities. Currently, the use of SCS is contraindicated in pregnancy. Nevertheless, many SCS/
neuromodulation recipients are women of child bearing age who may become pregnant. There are
no published reports that focus on the possible side effects of SCS or neuromodulation therapy on
human fertility, fetal development, pregnancy, delivery, or lactation.
Objectives: The purpose of this current report is to present a case study on the use of SCS/
neuromodulation during pregnancy.
Study Design: Presentation of the case of a 24 year old female who became pregnant after
receiving an SCS implantation for pain control secondary to complex regional pain syndrome (CRPS).
The SCS was in use at the time of conception but deactivated when patient became aware of her
pregnancy and intermittently reactivated for five minute intervals throughout the entire pregnancy.
Results: Currently very little documented evidence is available regarding the safety of using a SCS/
neuromodulator during pregnancy; therefore its use during pregnancy is contraindicated. Available
literature suggests that, women who have chosen to keep the SCS/neuromodulator activated
during pregnancy have delivered healthy babies without any life threatening complications.
Limitations: Case presentations do not provide conclusive evidence of treatment effectiveness.
This data is only preliminary and future studies should be used to assess outcomes and measures to
provide quantification of the SCS implantation during pregnancy.
Conclusions: Women of child bearing age who are recipients of SCS/neuromodulation
implantation should be informed of the limited knowledge available regarding the impact of SCS/
neuromodulation use during pregnancy. For current recipients, decisions about ongoing use during
pregnancy should be an individual decision based on the potential risks and benefits.
Key words: Pregnancy and complex regional pain syndrome, pregnancy and reflex sympathetic
dystrophy, pregnancy and spinal cord stimulators, pregnancy and electromagnetic fields, and
pregnancy and neuromodulator.